Published in Am J Psychiatry on May 01, 1989
Impact of stress on cancer metastasis. Future Oncol (2010) 1.52
Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev (1995) 1.47
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal (2011) 1.32
Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry (2012) 0.98
Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm (2001) 0.98
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur Arch Psychiatry Clin Neurosci (1997) 0.89
The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) (2006) 0.80
Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population. Eur Arch Psychiatry Clin Neurosci (2008) 0.78
Methodological Issues in Cytokine Measurement in Schizophrenia. Indian J Psychol Med (2016) 0.77
The effect of deficient muscarinic signaling on commonly reported biochemical effects in schizophrenia and convergence with genetic susceptibility loci in explaining symptom dimensions of psychosis. Front Pharmacol (2014) 0.75
The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study. NPJ Schizophr (2015) 0.75
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature (1996) 8.02
In vivo specific antigen recognition by rosette forming cells. Nature (1970) 4.78
In vitro evaluation of immunosuppressive drugs. Nature (1969) 4.70
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med (1987) 4.38
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A (1994) 3.77
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet (1997) 3.68
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. J Immunol Methods (1977) 3.24
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. Proc Natl Acad Sci U S A (1971) 3.13
In vitro rosette inhibition by antihuman antilymphocyte serum. Correlation with skin graft prolongation in subhuman primates. Transplantation (1969) 3.12
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol (1997) 2.89
Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet (1999) 2.79
Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med (1998) 2.75
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia (2010) 2.65
T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med (1989) 2.51
Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur J Immunol (1996) 2.43
The key role of nucleosomes in lupus. Arthritis Rheum (1999) 2.26
A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity (1994) 2.26
A new in vitro test evaluating anti-lymphocyte serum potency. Transplant Proc (1969) 2.21
Studies on thymus products. II. Demonstration and characterization of a circulating thymic hormone. Immunology (1973) 2.17
Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes (1994) 2.17
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum Mol Genet (1997) 2.08
IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A (2009) 1.97
Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol (1990) 1.96
Fish consumption and cancer risk. Am J Clin Nutr (1999) 1.94
Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice. Clin Exp Immunol (1973) 1.93
Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human. Ann N Y Acad Sci (1975) 1.89
Establishment and characterization of a murine hybridoma secreting monoclonal anti-DNA autoantibody. J Immunol (1980) 1.88
Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol (1988) 1.87
Evaluation of T-cells and thymic serum factors in man using the rosette technique. Transplant Rev (1973) 1.87
Deficit of suppressor T cells in active multiple sclerosis. Lancet (1980) 1.83
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med (1997) 1.83
Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med (1992) 1.82
The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases. Clin Exp Immunol (1981) 1.82
Peanut agglutinin. I. A new tool for studying T lymphocyte subpopulations. J Immunol (1978) 1.80
Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol (2013) 1.79
A monoclonal anti-DNA antibody also binds to cell-surface protein(s). Proc Natl Acad Sci U S A (1984) 1.75
A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol (1995) 1.74
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol (2001) 1.70
Selected food intake and risk of endometriosis. Hum Reprod (2004) 1.70
Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med (1978) 1.67
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation (1999) 1.67
Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum (1999) 1.67
Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet (1997) 1.65
Thymus dependency of rosette-forming cells: evidence for a circulating thymic hormone. Transplant Proc (1972) 1.63
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.63
Antigen recognition by T lymphocytes. II. Similar effects of azathioprine, antilymphocyte serum, and anti-theta serum on rosette-forming lymphocytes in normal and neonatally thymectomized mice. Cell Immunol (1972) 1.62
Phenomenological and comorbid features associated in obsessive-compulsive disorder: influence of age of onset. J Affect Disord (2004) 1.61
Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol (2005) 1.57
Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin. Diabetes (1990) 1.57
Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol Reprod Biol (1999) 1.57
The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med (1995) 1.56
Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum (1997) 1.55
Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J Immunol (1998) 1.55
The rheumatoid rosette. A diagnostic test unifying seropositive and seronegative rheumatoid arthritis. Am J Med (1970) 1.55
In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation (1990) 1.53
Early affect of adult thymectomy. Nat New Biol (1971) 1.53
Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum (2000) 1.52
Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells. Am J Transplant (2013) 1.52
Dietary factors and the risk of psoriasis. Results of an Italian case-control study. Br J Dermatol (1996) 1.51
The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol (1984) 1.46
A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control (1999) 1.45
The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol (1993) 1.44
Binding of autologous erythrocytes to immature T-cells. Proc Natl Acad Sci U S A (1975) 1.43
Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin Exp Immunol (1981) 1.42
Thymic hormone-containing cells. Characterization and localization of serum thymic factor in young mouse thymus studied by monoclonal antibodies. J Exp Med (1982) 1.42
Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer (2001) 1.42
Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells. Clin Exp Immunol (1980) 1.40
Cyclosporin and autoimmune disease. Lancet (1991) 1.39
Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39
Contribution of zinc and other metals to the biological activity of the serum thymic factor. Proc Natl Acad Sci U S A (1982) 1.37
Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur J Immunol (1982) 1.37
Antigen recognition by T lymphocytes. Thymus and marrow dependence of spontaneous rosette forming cells in the mouse. Cell Immunol (1972) 1.37
Reproductive factors and risk of uterine fibroids. Epidemiology (1996) 1.36
Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage. J Endocrinol (1996) 1.35
Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol (1991) 1.34
Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence. J Biol Chem (1977) 1.34
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. N Engl J Med (1989) 1.34
Thymic factors. Prog Allergy (1976) 1.33
Non-genomic effects of steroids. Interactions of steroid molecules with membrane structures and functions. Biochim Biophys Acta (1983) 1.32
Correlation between mixed lymphocyte culture performed before renal transplantation and kidney function. Clin Exp Immunol (1970) 1.32
Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest (1985) 1.31
In vitro detection of immunosuppressive activity of anti-lymphocyte sera. Nature (1968) 1.30
Evidence for a serum-factor secreted by the human thymus. Lancet (1972) 1.30
Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000. Heart (2006) 1.29
Structural study of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification. J Biol Chem (1977) 1.28
Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics (1992) 1.28
Detection of humoral and cell-mediated immunity to kidney basement membranes in human renal diseases. Am J Med (1972) 1.28
Studies on thymus products. 3. Epithelial origin of the serum thymic factor. Immunology (1974) 1.27
The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes? Mol Cell Endocrinol (2008) 1.27
Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc Natl Acad Sci U S A (1988) 1.26
CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut (1998) 1.25
Serum thymulin in human zinc deficiency. J Clin Invest (1988) 1.23
Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol (1996) 1.22